The main aim of this conference is to provide a platform to all the Scientists, Doctors, Medical professionals, Business delegates who will undoubtedly enhance the conference by giving their views regarding latest advancements to all the attendees.
The market of cell therapy in terms of revenues is $3 billion and its global market is poised to grow at a CAGR of 23.27% during the period 2017-2021. The market of stem cell therapy is expected to reach USD 145.8 million by 2021, growing at a CAGR of 11.0% during the forecast period 2016-2021. The global stem cell therapy market on the basis of the mode of treatment is segmented into allogenic and autologous stem cell therapy. Moreover, the gene therapy market in spite of presenting few marketable products and being nascent in terms of revenue generation holds tremendous growth potential. As per a new estimation carried out in a latest study, the global gene therapy industry has the potential to become a multi-million dollar industry by the end of 2018 as new products, especially those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.
About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the latest developments in these fields.
Why Atlanta?
As both cell and gene therapy has gained many applauds from all over the world, due to this reason these therapies are given much more importance from the beginning of their inceptions. Cell and gene therapies both are well performed worldwide in order to treat many types of diseases like SCID, cancer, cardiovascular diseases Type 1 diabetes and many more. In spite of many legal and ethical issues, these therapies are now accepted worldwide but still face many challenges in some countries and this is the reason that many people are still out of reach of their benefits especially on human health. According to ClinicalTrials.gov, North America has conducted maximum number of studies related to cell therapy (3,259) and stem cell research (2,449) among other countries which shows a huge scope for promoting the benefits of both cell therapy and stem cell research by the scientists, researchers and clinical industries to treat many diseases which do not have a proper treatment till date. Gene therapy products have not been currently approved by US FDA and therefore gene therapy products are still in the investigational stage. Some of the promising treatments that are not yet licensed are mainly available through a clinical trial. As many recent researches have been conducted in USA on human diseases by using different animal models, hence it has resulted in development of new technologies, new therapies and showed exciting improvements in disease treatments. Therefore positive hopes lies with these therapies in future also in spite of failures and non-approval. Advancements in cell and gene therapy products in USA are just one step away.